The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), is inviting proposals for the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research. This opportunity seeks innovative research projects aimed at enhancing military and civilian healthcare, focusing on key areas such as Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine. The BAA emphasizes the importance of basic and applied research to improve medical solutions for both the Armed Forces and the general public, with a highly competitive selection process anticipated due to the expected volume of high-quality submissions. Interested applicants can submit pre-proposals at any time until September 30, 2027, via the electronic Biomedical Research Application Portal (eBRAP), with full proposals submitted through Grants.gov. For further inquiries, applicants may contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

HT9425-23-S-BAA1-GG.pdf

The U.S. Army Medical Research and Development Command has announced a Broad Agency Announcement (BAA) for extramural medical research funding, which will be open from October 1, 2022, to September 30, 2027. The BAA focuses on various military medical research programs, including those for infectious diseases, combat casualty care, operational medicine, and medical defense against biological and chemical threats, emphasizing innovation in research proposals that benefit both military and civilian health. Interested applicants are required to submit pre-proposals through eBRAP, follow up with full proposals via Grants.gov, and adhere to specific guidelines pertaining to funding mechanisms, proposal content, and review processes.

HT9425-23-S-BAA1-posted.pdf

The FY23-FY27 Department of Defense (DOD) Broad Agency Announcement (BAA) for Extramural Medical Research, issued by the U.S. Army Medical Research and Development Command (USAMRDC), invites proposals for innovative research projects to enhance military and civilian healthcare. This solicitation, valid from October 1, 2022, to September 30, 2027, is continuously open and encourages applications related to three key areas: Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine. Applicants must follow specific submission guidelines through Grants.gov and eBRAP, ensuring their proposals align with DOD objectives.

This BAA emphasizes the need for basic and applied research aimed at improving medical solutions for the Armed Forces and the general public, highlighting the competitive nature of the selection process due to anticipated high-quality submissions and limited funding availability. It outlines the eligibility criteria for organizations, emphasizes the importance of collaboration with military and VA resources, and details the requirements for clinical trials and data sharing. The USAMRDC seeks innovative approaches that enhance readiness and performance while ensuring that all proposals are ethically sound and comply with regulatory standards.

The USAMRDC&#8217;s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&amp;T), operational requirements, military threat assessments, and national defense strategies. Extramural research and development programs play a vital role in the fulfillment of the objectives established by the USAMRDC. General information on the USAMRDC can be obtained at https://mrdc.health.mil/.This BAA is intended to solicit extramural research and development ideas using the authority provided by 10 USC 4001. The BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in FAR 6.102(d)(2) and 35.016 and in Department of Defense Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 35.016, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funded through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA utilizes competitive procedures in accordance with 10 USC 2302(2)(B) for the selection for award of S&amp;T proposals/applications. For the purposes of this BAA, S&amp;T includes activities involving basic research, applied research, advanced technology development, and, under certain conditions, may include activities involving advanced component development and prototypes.The selection process is highly competitive, and the quantity of meaningful submissions (both pre-proposals/pre-applications and full proposals/applications) received typically exceeds the number of awards that available funding can support.This BAA provides a general description of USAMRDC&#8217;s research and development programs, including Research Areas of Interest, evaluation and selection criteria, pre-proposal/ pre-application and full proposal/application preparation instructions, and general administrative information. Specific submission information and additional administrative requirements can be found in the document titled, &#8220;General Submission Instructions,&#8221; which is available on Grants.gov along with this BAA.The FY23-FY27 USAMRDC BAA is continuously open for a 5-year period, from October 1, 2022 through September 30, 2027, at 11:59 p.m. Eastern Time. Submission of a pre-proposal/pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period. If the USAMRDC is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this FY23-FY27 BAA through September 30, 2027.

CDMRP Help Desk &lt;br/&gt;Phone: 301-682-5507 &lt;br/&gt;Email:  help@eBRAP.org

Buyer

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source